Groupon Cofounder ' s Health Startup Hits $2 Billion Valuation With Latest Funding Round
The Chicago-based company raised $110 million in its Series E financing and plans to use its funds to extend its focus beyond oncology treatment, and into areas like cardiovascular disease and diabetes.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news
More News: Cancer & Oncology | Cardiology | Cardiovascular | Diabetes | Endocrinology | Funding | Heart | Pharmaceuticals